Related Experiment Video
Updated: May 29, 2025

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
Published on: August 3, 2018
Reaction Pathway Differentiation Enabled Fingerprinting Signal for Single Nucleotide Variant Detection
Huixiao Yang1, Linghao Zhang1, Xinmiao Kang1
1State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
A novel differential reaction pathway probe (DRPP) accurately identifies single-nucleotide variants (SNVs) using machine learning. This method significantly improves diagnostic accuracy and sensitivity for diseases like COVID-19 and cancer.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Bioinformatics
Background:
- Accurate single-nucleotide variant (SNV) identification is crucial for disease diagnosis.
- Conventional DNA hybridization probes have limited specificity, hindering clinical applications.
- Existing methods for SNV detection often lack the required sensitivity and accuracy.
Purpose of the Study:
- To develop a novel detection method, the differential reaction pathway probe (DRPP), for highly accurate SNV identification.
- To leverage dynamic DNA reaction networks and machine learning for enhanced signal analysis and classification.
- To improve sensitivity for variant allele frequency (VAF) detection and demonstrate clinical applicability.
Main Methods:
- A differential reaction pathway probe (DRPP) based on a dynamic DNA reaction network was designed.
- DRPP utilizes differences in reaction intermediate concentrations to create distinct signal pathways for SNVs and wild-type (WT) DNA.
- Machine learning algorithms were applied to analyze fluorescence kinetic data for automated classification.
Main Results:
- DRPP achieved 99.6% accuracy in classifying SNV and WT signals, surpassing conventional methods (80.7%).
- Sensitivity for VAF detection was enhanced to 0.1%, a ten-fold improvement.
- Accurate identification of SARS-CoV-2 SNVs (D614G, N501Y) and cancer mutations (KRAS, NRAS, BRAF) in clinical samples was demonstrated.
Conclusions:
- DRPP offers a highly accurate and sensitive method for SNV detection, outperforming traditional approaches.
- The technology shows significant potential for clinical diagnostics, including early disease detection and personalized medicine.
- Integration with rapid amplification techniques could further enhance DRPP's clinical utility.
More Related Videos
Related Concept Videos
Sanger Sequencing
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

